Our novel therapy for eliminating cancer tumors, MFA370, will be tested in clinical trials on metastatic bladder cancer. Preclinical studies have shown positive results in inducing cell death in breast, colorectal and prostate cancer cells too. MFA370 is planned to be a simple oral tablet with few if any side effects. It is a combination of two safe, standard, well-established pharmaceuticals that have already undergone large-scale clinical trials.
| Website | https://www.ectinresearch.com |
| Revenue | $5 million |
| Employees | 1 (0 on RocketReach) |
| Address | 1 Pepparedsleden, Moelndal, Vaestra Goetaland 431 83, SE |
| Phone | +46 70 645 08 75 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Medical, Manufacturing, Health Care, Pharmaceutical, Therapeutics |
| Keywords | Cancer Treatment, Cancer Therapy, Oncology Research, Drug Development, Pharmaceutical Research, Cancer Research, Clinical Trials, Biotechnology, Novel Therapy, Metastatic Cancer, Breast Cancer Treatment, Bladder Cancer Treatment, Preclinical Studies, Prostate Cancer Treatment |
| Competitors | Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., QIAGEN, PacBio, GenomeWeb, Bio-Rad Magyarország Kft. +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Ectin Research employee's phone or email?
Ectin Research Questions
The Ectin Research annual revenue was $5 million in 2026.
Ectin Research is based in Moelndal, Vaestra Goetaland.
The NAICS codes for Ectin Research are [3254, 325, 32541, 32].
The SIC codes for Ectin Research are [283, 28].
Related Companies
